21 CFR 524.1484i
§ 524.1484i Neomycin and hydrocortisone ointment.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 524.1484i, § 524.1484i Neomycin and hydrocortisone ointment, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87638
- Permanent ID
ys:prov:87638@1- SHA-256
44cb70b2e3e447a5c93ca7f2ad46f8868aa639cfaa845d3d9cef82dc3eb84a0f
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. The drug contains 5 milligrams of neomycin sulfate, equivalent to 3.5 milligrams of neomycin base, and 5 milligrams of hydrocortisone acetate in each gram of ointment. 1
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats—(1) Amount. Apply 3 or 4 times daily into the conjunctival sac. With improvement, frequency may be reduced to 2 or 3 times daily. For treatment of ear canker and other inflammatory conditions of the external ear canal, fill external ear canal 1 to 3 times daily.
(2) Indications for use. For the treatment of infections, allergic and traumatic keratitis, conjunctivitis, acute otitis externa and, to a lesser degree, chronic otitis externa.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.